Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
Provided are methods of detecting the presence or amount of a dihydroxyvitamin D metabolite in a sample using mass spectrometry. The methods generally comprise ionizing a dihydroxyvitamin D metabolite in a sample and detecting the amount of the ion to determine the presence or amount of the vitamin D metabolite in the sample. In certain preferred embodiments the methods include immunopurifying the dihydroxyvitamin D metabolites prior to mass spectrometry. Also provided are methods to detect the presence or amount of two or more dihydroxyvitamin D metabolites in a single assay.
1. A method for determining an amount of one or more dihydroxyvitamin D metabolites in a biological sample taken by tandem mass spectrometry; the method comprising:
(i) generating at least one precursor ion respectively of the one or more dihydroxyvitamin D metabolites and of an internal standard by ionizing the one or more dihydroxyvitamin D metabolites and the internal standard with atmospheric pressure chemical ionization (APCI);
(ii) generating one or more fragment ions of the precursor ion respectively of the one or more dihydroxyvitamin D metabolites and of the internal standard; and
(iii) comparing amounts of one or more of the ions generated in step (i), (ii), or both, for the one or more dihydroxyvitamin D metabolites and the internal standard to determine the amount of the one or more dihydroxyvitamin D metabolites in the biological sample;
wherein the one or more dihydroxyvitamin D metabolites are not subject to derivatization.
2. The method of claim 1 , wherein the internal standard comprises at least one of 1α,25(OH) 2 D 2 -[26,26,26,27,27,27]- 2 H and 1α,25(OH) 2 D 3 -[6,19,19′]- 2 H.
3. The method of claim 1 , wherein the one or more dihydroxyvitamin D metabolites comprise at least one of 1α,25(OH) 2 D 2 and 1α,25(OH) 2 D 3 .
4. The method of claim 1 , wherein the one or more dihydroxyvitamin D metabolites comprise 1α,25(OH) 2 D 2 and 1α,25(OH) 2 D 3 and wherein the amount of the metabolites are determined in a single assay.
5. The method of claim 1 , wherein the one or more dihydroxyvitamin D metabolites comprise 1α,25(OH) 2 D 2 and wherein the precursor ion of the 1α,25(OH) 2 D 2 has a mass/charge ratio of 411.35±0.5.
6. The method of claim 5 , wherein the one or more fragment ions comprise one or more ions selected from the group consisting of ions having a mass/charge ratio of 151.12±0.5 and 135.12±0.5.
7. The method of claim 1 , wherein the one or more dihydroxyvitamin D metabolites comprise 1α,25(OH) 2 D 3 and wherein the precursor ion of the 1α,25(OH) 2 D 3 has a mass/charge ratio of 399.35±0.5.
8. The method of claim 7 , wherein the one or more fragment ions comprise one or more ions selected from the group consisting of ions having a mass/charge ratio of 151.12±0.5 and 135.12±0.5.
9. The method of claim 1 , wherein the internal standard comprises 1α,25(OH) 2 D 2 -[26,26,26,27,27,27]- 2 H and the at least one precursor ion thereof has a mass/charge ratio of 577.37.
10. The method of claim 9 , wherein the one or more fragment ions of the internal standard have a mass/charge ratio of 317.12.
11. The method of claim 1 , wherein the internal standard comprises 1α,25(OH) 2 D 3 -[6,19,19′]- 2 H and the at least one precursor ion thereof has a mass/charge ratio of 592.37.
12. The method of claim 11 , wherein the one or more fragment ions of the internal standard have a mass/charge ratio of 314.12.
13. The method of claim 1 , further comprising purifying the one or more dihydroxyvitamin D metabolites from the biological sample prior to ionization.
14. The method of claim 1 , further comprising constructing a standard curve based on the precursor and fragment ions of the internal standard and determining the amount of the one or more dihydroxyvitamin D metabolites in the biological sample using the standard curve.
15. A method for determining the amount of one or more dihydroxyvitamin D metabolites in a biological sample by tandem mass spectrometry; the method comprising:
(a) derivatizing the dihydroxyvitamin D metabolites from the biological sample with 4′-carboxyphenyl-TAD; and
(b) determining the amount of the derivatized vitamin D metabolites obtained from step (a) by tandem mass spectrometry comprising:
(i) generating at least one precursor ion respectively of the one or more dihydroxyvitamin D metabolites and of an internal standard;
(ii) generating one or more fragment ions of the at least one precursor ion respectively of the one or more dihydroxyvitamin D metabolites and of the internal standard; and
(iii) comparing amounts of one or more of the ions generated in step (i), (ii), or both, for the one or more dihydroxyvitamin D metabolites and the internal standard to determine the amount of the one or more dihydroxyvitamin D metabolites in the biological sample.
16. The method of claim 15 , further comprising purifying the one or more dihydroxyvitamin D metabolites from the biological sample prior to mass spectrometry.
17. The method of claim 16 , wherein the purification comprises at least one of immunopurification, high performance liquid chromatography (HPLC), and high turbulence liquid chromatography (HTLC).
18. The method of claim 16 , further comprising adding the internal standard to the biological sample prior to the purification.
19. The method of claim 15 , wherein the internal standard comprises at least one of 1α,25(OH) 2 D 2 -[26,26,26,27,27,27]- 2 H and 1α,25(OH) 2 D 3 -[6,19,19′]- 2 H.
20. The method of claim 15 , wherein the one or more dihydroxyvitamin D metabolites comprise at least one of 1α,25(OH) 2 D 2 and 1α,25(OH) 2 D 3 .